Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 45: 904-906, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarez, L.
Right arrow Articles by Ballesta, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarez, L.
Right arrow Articles by Ballesta, A. M.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:904-906.)
© 1999 American Association for Clinical Chemistry, Inc.


Technical Briefs

Collagen Type I {alpha}1 Gene Sp1 Polymorphism in Premenopausal Women with Primary Osteoporosis: Improved Detection of Sp1 Binding Site Polymorphism in the Collagen Type 1 Gene

Luisa Alvarez1, Josep Oriola2, Judith Jo1, Teresa Ferró1, Francesca Pons3, Pilar Peris4, Nuria Guañabens4, Magdalena Durán5, Ana Monegal4, M. Jesús Martínez de Osaba2, Francisca Rivera-Fillat2 and Antonio M. Ballesta1

1 Biochemistry,
2 Hormonology,
3 Nuclear Medicine,
4 Rheumatology, and
5 Gynaecology, Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain;

Osteoporosis is a common disorder characterized by reduced bone mass and increased risk of fracture (1). Evidence from family studies suggests that genetic factors have a major role in the determination of bone mass (2). Because bone mass and bone strength are complex phenotypes, their heredity is almost certainly polygenic. Among the potential candidate genes that might influence bone mass acquisition, special attention has been directed to the vitamin D receptor and estrogen receptor genes; results of these studies, however, have been contradictory (3)(4)(5). Type I collagen, a protein encoded by the collagen I {alpha}1 (COLIA1) and collagen I {alpha}2 (COLIA2) genes, is the major protein of bone matrix. Genes encoding collagen type I may be important candidates for the genetic regulation of bone density because mutations that affect their coding regions have been associated with osteogenesis imperfecta (6).

A guanine-to-thymidine polymorphism at the first base of a binding site for the transcription factor Sp1 in the first intron of COLIA1 has recently been associated with low bone density and bone fractures in women from various European populations(7)(8)(9)(10)(11). In these studies, the COLIA1 genotypes were determined using a PCR assay with a mismatched primer that introduces a restriction site for the enzyme BalI in polymorphic alleles with the thymidine substitution. The test discriminates two alleles, S and s, which correspond to the presence of guanine and thymidine, respectively. Thus, the absence of the restriction site on both alleles was defined as homozygote SS, the presence of the restriction site was defined as homozygote ss, and the combination of both was defined as heterozygote Ss (7). In this assay, the PCR products containing . . . [Full Text of this Article]


Footnotes


References




The following articles in journals at HighWire Press have cited this article:


Home page
Rheumatology (Oxford)Home page
P. Peris, L. Alvarez, J. Oriola, N. Guanabens, A. Monegal, M. J. M. de Osaba, J. Jo, F. Pons, A. M. Ballesta, and J. Munoz-Gomez
Collagen type I{alpha}1 gene polymorphism in idiopathic osteoporosis in men
Rheumatology, November 1, 2000; 39(11): 1222 - 1225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.